Welcome to LookChem.com Sign In|Join Free

CAS

  • or

367274-58-6

Post Buying Request

367274-58-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

367274-58-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 367274-58-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,6,7,2,7 and 4 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 367274-58:
(8*3)+(7*6)+(6*7)+(5*2)+(4*7)+(3*4)+(2*5)+(1*8)=176
176 % 10 = 6
So 367274-58-6 is a valid CAS Registry Number.

367274-58-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-benzyloxy-4,4-dimethyl-5(4H)-oxazolone

1.2 Other means of identification

Product number -
Other names 2-(benzyloxy)-4,4-dimethyloxazol-5(4H)-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:367274-58-6 SDS

367274-58-6Relevant articles and documents

Discovery of diamide compounds as diacylglycerol acyltransferase 1 (DGAT1) inhibitors

Nakajima, Katsumasa,April, Myriam,Brewer, Jason T.,Daniels, Thomas,Forster, Cornelia J.,Gilmore, Thomas A.,Jain, Monish,Kanter, Aaron,Kwak, Youngshin,Li, Jingzhou,McQuire, Les,Serrano-Wu, Michael H.,Streeper, Ryan,Szklennik, Paul,Thompson, James,Wang, Bing

, p. 1245 - 1248 (2016)

Diamide compounds were identified as potent DGAT1 inhibitors in vitro, but their poor molecular properties resulted in low oral bioavailability, both systemically and to DGAT1 in the enterocytes of the small intestine, resulting in a lack of efficacy in vivo. Replacing an N-alkyl group on the diamide with an N-aryl group was found to be an effective strategy to confer oral bioavailability and oral efficacy in this lipophilic diamide class of inhibitors.

Linear oligopeptides. Part 329. Synthesis, characterization and solution conformational analysis of Cα-ethyl, Cα-benzylglycine containing peptides

Formaggio, Fernando,Pantano, Monica,Crisma, Marco,Bonora, Gian Maria,Toniolo, Claudio,Kamphuis, Johan

, p. 1097 - 1102 (2007/10/02)

For the first time a variety of derivatives and terminally blocked model peptides (to the pentapeptide level) of the sterically demanding (αEt)Phe residue have been synthesized (by solution methods) and fully characterized.The results of a solution conformational analysis, performed by using FTIR and 1H NMR spectroscopy, favour the conclusion that (αEt)Phe is a β-turn and helix promoter as strong as (αMe)Phe (Cα-methyl, Cα-benzylglycine) but more efficient than the Phe parent amino acid.In addition, a CD study of Nα-para-bromobenzoylated peptides suggests that the relationship between (αEt)Phe chirality and the screw sense of the turn and helical structures that are formed is the same as that found for (αMe)Phe peptides, i.e.L-amino acids give left-handed helicities.Interestingly, this relationship is opposite to that exhibited by protein amino acids, including Phe.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 367274-58-6